# Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder

> **NCT06545916** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Imbrium Therapeutics** · enrollment: 200 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Sunobinop
- **DRUG:** Placebo to match sunobinop

## Key facts

- **NCT ID:** NCT06545916
- **Lead sponsor:** Imbrium Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-10-14
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06545916

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06545916, "Study of Sunobinop on Alcohol Consumption in Alcohol Use Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06545916. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*